Engineering of Cas12a nuclease variants with enhanced genome-editing specificity
PLOS Biology · 14.03.2024 · 22 (3) · e3002514
DOI: 10.1371/journal.pbio.3002514 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 14.03.2024. Verfasst von Peng Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Department of Clinical Oncology, Renmin Hospita…. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The clustered regularly interspaced short palindromic repeat (CRISPR)-Cas12a system is a powerful tool in gene editing; however, crRNA-DNA mismatches might induce unwanted cleavage events, especially at the distal end of the PAM. To minimize this limitation, we engineered a hyper fidelity AsCas12a variant carrying the mutations S186A/R301A/T315A/Q1014A/K414A (termed HyperFi-As) by modifying amino acid residues interacting with the target DNA and crRNA strand. HyperFi-As retains on-target activities comparable to wild-type AsCas12a (AsCas12aWT) in human cells. We demonstrated that HyperFi-As has dramatically reduced off-target effects in human cells, and HyperFi-As possessed notably a lower tolerance to mismatch at the position of the PAM-distal region compared with the wild type. Further, a modified single-molecule DNA unzipping assay at proper constant force was applied to evaluate the stability and transient stages of the CRISPR/Cas ribonucleoprotein (RNP) complex. Multiple states were sensitively detected during the disassembly of the DNA-Cas12a-crRNA complexes. On off-target DNA substrates, the HyperFi-As-crRNA was harder to maintain the R-loop complex state compared to the AsCas12aWT, which could explain exactly why the HyperFi-As has low off-targeting effects in human cells. Our findings provide a novel version of AsCas12a variant with low off-target effects, especially capable of dealing with the high off-targeting in the distal region from the PAM. An insight into how the AsCas12a variant behaves at off-target sites was also revealed at the single-molecule level and the unzipping assay to evaluate multiple states of CRISPR/Cas RNP complexes might be greatly helpful for a deep understanding of how CRISPR/Cas behaves and how to engineer it in future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Department of Clinical Oncology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
- The Institute for Advanced Studies, College of Life Sciences, State Key Laboratory of Virology, Hubei Key Laboratory of Cell Homeostasis, Wuhan University, Wuhan, China.
- The Faculty of Life Science, KIM IL SUNG University, Pyongyang, Democratic People's Republic of Korea.
ORCID-Profile: Lei Yin
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- China Postdoctoral Science Foundation
- the National Key R&D Program of China
- the National Natural Science Foundation of China
- the Fundamental Research Funds for the Central Universities
- the China Postdoctoral Science Foundation
Zitieren
APA
Chen, P., Zhou, J., Liu, H., Zhou, E., He, B., Wu, Y., Wang, H., Sun, Z., Paek, C., Lei, J., Chen, Y., Zhang, X., & Yin, L. (2024). Engineering of Cas12a nuclease variants with enhanced genome-editing specificity. PLOS Biology, 22(3), e3002514. https://doi.org/10.1371/journal.pbio.3002514
Vancouver
Chen P, Zhou J, Liu H, Zhou E, He B, Wu Y, et al. Engineering of Cas12a nuclease variants with enhanced genome-editing specificity. PLOS Biology. 2024;22(3):e3002514. doi:10.1371/journal.pbio.3002514
BibTeX
@article{Chen2024,
author = {Chen, Peng and Zhou, Jin and Liu, Huan and Zhou, Erchi and He, Boxiao and Wu, Yankang and Wang, Hongjian and Sun, Zaiqiao and Paek, Chonil and Lei, Jun and Chen, Yongshun and Zhang, Xinghua and Yin, Lei},
title = {Engineering of Cas12a nuclease variants with enhanced genome-editing specificity},
journal = {PLOS Biology},
year = {2024},
volume = {22},
number = {3},
pages = {e3002514},
doi = {10.1371/journal.pbio.3002514}
}
EUVIMED